Literature DB >> 27578619

The correlation between plasma levels of oxytocin and betatrophin in non-diabetic and diabetic metabolic syndrome patients: A cross sectional study from Jordan.

Amani Al-Rawashdeh1, Violet Kasabri2, Nailya Bulatova1, Amal Akour1, Ayman Zayed1, Munther Momani1, Nahla Khawaja3, Haider Bustanji3, Dana Hyasat3.   

Abstract

BACKGROUND: Oxytocin (OXT) is a neurohypophyseal hormone that has been recently shown to possess a number of beneficial effects in diabetes and obesity. Betatrophin is a protein expressed in fat and liver that regulates lipid metabolism and promotes pancreatic β-cell proliferation. It is not investigated yet whether OXT and betatrophin levels correlate in metabolic syndrome (MS) or diabetes patients.
METHODS: The aim was to assess correlations between plasma betatrophin and OXT levels in MS-diabetic or prediabetic (N=89) as compared to MS-non-diabetic (N=69) patients. Competitive binding ELISA was used to evaluate betatrophin and OXT plasma concentrations. Correlations of the above biomarkers and patient clinical characteristics were also detected.
RESULTS: As compared to the control MS participants (0.32±0.25ng/mL); betatrophin plasma levels were increased (P<0.001) in the MS-pre/T2DM patients (1.23±0.68ng/mL). On the contrary, OXT concentrations were decreased (P<0.001) in the MS-pre/T2DM patients (1222.46±514.55pg/mL) as compared to the MS control subjects (2323.42±848.68pg/mL). OXT concentration correlated negatively (r=-0.492, P<0.001), while HbA1c and FPG correlated positively with betatrophin plasma levels (P<0.001), but were inversely correlated with OXT levels (P<0.001) in the total sample.
CONCLUSION: Betatrophin levels are increased, while OXT levels are decreased in MS-pre/T2DM. We found an inverse correlation between the levels of the two biomarkers in addition to correlation between their levels and the degree of glycemic control.
Copyright © 2016 Diabetes India. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Betatrophin; Enzyme linked immunosorbent assays; Metabolic syndrome; Oxytocin; Type 2 diabetes mellitus

Mesh:

Substances:

Year:  2016        PMID: 27578619     DOI: 10.1016/j.dsx.2016.08.008

Source DB:  PubMed          Journal:  Diabetes Metab Syndr        ISSN: 1871-4021


  7 in total

1.  Prevalence of Cardiovascular Diseases Risk Factors among Jordanians.

Authors:  Wesam Alsaud; Mohammad J Tabbaa; Violet N Kasabri; Maysa F Suyagh; Muneer A Abu Alsamen; Hussain M Haddad; Anas O ALshweki
Journal:  J Saudi Heart Assoc       Date:  2020-08-03

2.  Oxytocin is lower in African American men with diabetes and associates with psycho-social and metabolic health factors.

Authors:  Yuval Eisenberg; Lara R Dugas; Arfana Akbar; Bharathi Reddivari; Brian T Layden; Elena Barengolts
Journal:  PLoS One       Date:  2018-01-04       Impact factor: 3.240

3.  Serum Concentrations of Betatrophin and Its Association with Indirect Indices of Insulin Resistance and Beta Cell Function in Women with Polycystic Ovary Syndrome.

Authors:  Agnieszka Adamska; Agnieszka Łebkowska; Małgorzata Jacewicz; Anna Krentowska; Justyna Hryniewicka; Sławomir Wołczyński; Maria Górska; Irina Kowalska
Journal:  Int J Endocrinol       Date:  2017-06-18       Impact factor: 3.257

4.  Association of serum sestrin 2 and betatrophin with serum neutrophil gelatinase associated lipocalin levels in type 2 diabetic patients with diabetic nephropathy.

Authors:  Khalid M Mohany; Osamah Al Rugaie
Journal:  J Diabetes Metab Disord       Date:  2020-02-06

5.  Association between circulating microRNAs 486, 146b and 15b and serum betatrophin levels in obese; type 2 diabetic and non-diabetic children.

Authors:  Khalid M Mohany; Osamah Al Rugaie; Osama Al-Wutayd; Abdullah Al-Nafeesah; Tahia H Saleem
Journal:  BMC Endocr Disord       Date:  2020-09-29       Impact factor: 2.763

Review 6.  Oxytocin in metabolic homeostasis: implications for obesity and diabetes management.

Authors:  C Ding; M K-S Leow; F Magkos
Journal:  Obes Rev       Date:  2018-09-25       Impact factor: 9.213

Review 7.  The Effects of Oxytocin on Appetite Regulation, Food Intake and Metabolism in Humans.

Authors:  Liya Kerem; Elizabeth A Lawson
Journal:  Int J Mol Sci       Date:  2021-07-20       Impact factor: 6.208

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.